88 related articles for article (PubMed ID: 27236270)
1. Genetic mutations in high grade gliomas of the adult spinal cord.
Nagaishi M; Nobusawa S; Yokoo H; Sugiura Y; Tsuda K; Tanaka Y; Suzuki K; Hyodo A
Brain Tumor Pathol; 2016 Oct; 33(4):267-269. PubMed ID: 27236270
[No Abstract] [Full Text] [Related]
2. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
[TBL] [Abstract][Full Text] [Related]
3. High frequency of H3F3A (K27M) mutations characterizes pediatric and adult high-grade gliomas of the spinal cord.
Gessi M; Gielen GH; Dreschmann V; Waha A; Pietsch T
Acta Neuropathol; 2015 Sep; 130(3):435-7. PubMed ID: 26231952
[No Abstract] [Full Text] [Related]
4. Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas.
Ellezam B; Theeler BJ; Walbert T; Mammoser AG; Horbinski C; Kleinschmidt-DeMasters BK; Perry A; Puduvalli V; Fuller GN; Bruner JM; Aldape KD
Acta Neuropathol; 2012 Sep; 124(3):449-51. PubMed ID: 22772980
[No Abstract] [Full Text] [Related]
5. Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas.
Sloan EA; Cooney T; Oberheim Bush NA; Buerki R; Taylor J; Clarke JL; Torkildson J; Kline C; Reddy A; Mueller S; Banerjee A; Butowski N; Chang S; Mummaneni PV; Chou D; Tan L; Theodosopoulos P; McDermott M; Berger M; Raffel C; Gupta N; Sun PP; Li Y; Shah V; Cha S; Braunstein S; Raleigh DR; Samuel D; Scharnhorst D; Fata C; Guo H; Moes G; Kim JYH; Koschmann C; Van Ziffle J; Onodera C; Devine P; Grenert JP; Lee JC; Pekmezci M; Phillips JJ; Tihan T; Bollen AW; Perry A; Solomon DA
Acta Neuropathol; 2019 Nov; 138(5):877-881. PubMed ID: 31515627
[No Abstract] [Full Text] [Related]
6. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.
Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A
Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431
[TBL] [Abstract][Full Text] [Related]
7. Diffuse midline gliomas with histone H3-K27M mutation: A rare case with PNET-like appearance and neuropil-like islands.
Gao Y; Feng YY; Yu JH; Li QC; Qiu XS; Wang EH
Neuropathology; 2018 Apr; 38(2):165-170. PubMed ID: 28880421
[TBL] [Abstract][Full Text] [Related]
8. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
[TBL] [Abstract][Full Text] [Related]
9. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
10. Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors.
Håvik AB; Lind GE; Honne H; Meling TR; Scheie D; Hall KS; van den Berg E; Mertens F; Picci P; Lothe RA; Heim S; Brandal P
Neuro Oncol; 2014 Jan; 16(2):320-2. PubMed ID: 24311631
[No Abstract] [Full Text] [Related]
11. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
[TBL] [Abstract][Full Text] [Related]
12. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas.
Ishi Y; Takamiya S; Seki T; Yamazaki K; Hida K; Hatanaka KC; Ishida Y; Oda Y; Tanaka S; Yamaguchi S
Brain Tumor Pathol; 2020 Jul; 37(3):81-88. PubMed ID: 32529280
[TBL] [Abstract][Full Text] [Related]
14. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
[TBL] [Abstract][Full Text] [Related]
15. Diffuse midline glioma with H3 K27M mutation of the spinal cord: A series of 33 cases.
Yao J; Wang L; Ge H; Yin H; Piao Y
Neuropathology; 2021 Jun; 41(3):183-190. PubMed ID: 33599007
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1
Kondo N; Barth RF; Miyatake SI; Kawabata S; Suzuki M; Ono K; Lehman NL
J Neurooncol; 2017 May; 133(1):107-118. PubMed ID: 28534152
[TBL] [Abstract][Full Text] [Related]
17. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma.
Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN
Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362
[TBL] [Abstract][Full Text] [Related]
18. Brain T1ρ mapping for grading and IDH1 gene mutation detection of gliomas: a preliminary study.
Cao M; Ding W; Han X; Suo S; Sun Y; Wang Y; Qu J; Zhang X; Zhou Y
J Neurooncol; 2019 Jan; 141(1):245-252. PubMed ID: 30414094
[TBL] [Abstract][Full Text] [Related]
19. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
Sanson M; Marie Y; Paris S; Idbaih A; Laffaire J; Ducray F; El Hallani S; Boisselier B; Mokhtari K; Hoang-Xuan K; Delattre JY
J Clin Oncol; 2009 Sep; 27(25):4150-4. PubMed ID: 19636000
[TBL] [Abstract][Full Text] [Related]
20. Driver Genetic Mutations in Spinal Cord Gliomas Direct the Degree of Functional Impairment in Tumor-Associated Spinal Cord Injury.
Nagashima Y; Nishimura Y; Ohka F; Eguchi K; Aoki K; Ito H; Nishii T; Oyama T; Hara M; Kitano Y; Masaki H; Wakabayashi T; Natsume A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
